Veritas raises $30M in series B

Diagnostics company Veritas Genetics International Ltd. (Danvers, Mass.) raised $30 million in a series B financing co-led by new investors Trustbridge Partners and the Jiangsu Simcere Pharmaceutical R&D Co. Ltd. unit of Simcere Pharmaceutical Group (Nanjing, China). Existing investor Lilly Asia Ventures also participated.

The company markets the myBRCA test to identify mutations in the BRCA1 and BRCA2 genes. In September 2015, Veritas said it was the first company to offer whole genome sequencing and interpretation services for less than $1,000. ...